Cranberry Consumption Improves γδ T Cell Function

NCT ID: NCT01713829

Last Updated: 2014-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the extent to which consuming a cranberry beverage modifies immune function, specifically related to γδ T cells and other innate immune cells. It is hypothesized that cranberry components will interact with immune cells to activate signaling pathways that enhance cell function. Enhanced immune cell function should result in reduced number, duration, and severity of cold and flu symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cranberry Beverage

Cranberry Beverage is provided in an 8 oz daily beverage consumed once daily for 12 weeks

Group Type EXPERIMENTAL

Cranberry Beverage

Intervention Type OTHER

8 oz cranberry beverage consumed daily for 12 weeks

Placebo Beverage

The placebo beverage looks like the active arm and is given in the same way but contains no active ingredient.

Group Type PLACEBO_COMPARATOR

Placebo Beverage

Intervention Type OTHER

8 oz placebo beverage consumed daily for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cranberry Beverage

8 oz cranberry beverage consumed daily for 12 weeks

Intervention Type OTHER

Placebo Beverage

8 oz placebo beverage consumed daily for 12 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 21 and 35 years of age and in good health
* have a BMI between 18.5 and 29.9
* willing to consume the study beverage for 12 weeks
* willing to have a small amount of blood drawn two times
* willing to stop consuming tea and immune-enhancing dietary supplements (e.g. antioxidant-, probiotic-, or flavonoid-containing supplements, fish oil, and Echinacea) before and during the 12 weeks of the study
* willing to consume no more than 7 servings of fruits and vegetables a day
* willing to limit your alcohol consumption to no more than 14 glasses a week
* willing to limit your yogurt consumption to no more than one 8oz. serving per day

Exclusion Criteria

* have food allergies
* have hypertension
* taking non-steroidal anti-inflammatory drugs on a chronic basis, antibiotics, or immunosuppressive drugs
* sensitive to aspirin or prone to kidney stones
* current smoker
* pregnant, lactating, or on hormone therapy, except for birth control pills
Minimum Eligible Age

21 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cranberry Institute

OTHER

Sponsor Role collaborator

University of Florida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susan S Percival, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Florida

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

449 Food Science and Human Nutrition Department, University of Florida

Gainesville, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CB-472-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immune Benefits of Coffee
NCT00860197 COMPLETED NA